Oxymorphone Hydrochloride Tablet
Product Images NDC 31722-929

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxymorphone Hydrochloride (NDC 31722-929). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

10 mg 100 Ct

10 mg 100 Ct
Label for Oxymorphone Hydrochloride Tablets, USP 10 mg by Camber Pharmaceuticals, Inc. The label states the product is oral tablets, with 100 tablets per bottle, and includes storage instructions, dispensing information, and manufacturer details. It also features a barcode and the NDC number 31722-930-01.*
FDA Label Image

5 mg 100 Ct

5 mg 100 Ct
Label for Oxymorphone Hydrochloride Tablets, USP 5 mg oral tablets by Camber Pharmaceuticals, Inc. The label notes 100 tablets per container, includes dosage information, storage instructions at 20ºC-25ºC, and warnings about the child-resistant container. It also identifies Ascent Pharmaceuticals, Inc. as the manufacturer.*
FDA Label Image

Structure

Structure
Chemical structure of oxymorphone hydrochloride depicted in a black and white diagram showing the arrangement of atoms and bonds, including hydroxyl groups and a methyl group, as part of the molecular structure.*
FDA Label Image

Table 2

Table 2
A detailed drug interaction text panel for oxymorphone hydrochloride tablets. The panel covers interactions with alcohol, benzodiazepines and other CNS depressants, serotonergic drugs, monoamine oxidase inhibitors (MAOIs), mixed agonist/antagonist opioids, muscle relaxants, diuretics, anticholinergic drugs, and cimetidine. It describes clinical impacts, interventions, and examples for co-administration risks and cautions.*
FDA Label Image

Table 1

Table 1
Data table showing adverse reactions reported in placebo-controlled trials comparing Oxymorphone Hydrochloride Tablets (N=557) and placebo (N=270). The table lists side effects with corresponding percentages for Oxymorphone Hydrochloride and placebo groups, including nausea, pyrexia, somnolence, vomiting, pruritus, headache, dizziness (excluding vertigo), constipation, and confusion.*
FDA Label Image

Table 3

Table 3
A data table presenting mean pharmacokinetic parameters (Cmax, AUC, T1/2) with standard deviations for Oxycodone Hydrochloride tablets at multiple dosages (5 mg, 10 mg, 20 mg) under single dose and multiple dose regimens. The table includes notes on NA values and dosing frequency for multiple doses.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.